Products Affected - Description
All presentations are currently available
Reason for the Shortage
- Hospira states the shortage was due to increased demand.
- Fresenius Kabi reduced production of sterile empty vials to permit increased production of drug products affected by critical shortages.
- Sterile empty vials may be available from medical supply distributors.
Empty Sterilized Vials, Fresenius Kabi
5 mL, 25 count (NDC 63323-0001-05)
10 mL, 25 count (NDC 63323-0001-10)
30 mL, 25 count (NDC 63323-0001-30)
100 mL, 40 count (NDC 63323-0001-00)
Sterile Empty Vials, Hospira
10 mL, 50 count (List #05816-11)
30 mL, 50 count (List #05816-31)
Estimated Resupply Dates
All presentations are available.
January 20, 2017; December 5, November 7, August 5, May 12, March 22 and 1, 2016; December 11, November 4, August 12 and 11, June 9, April 7, March 24, January 15 and 14, 2015; November 3, September 30, August 8, July 14, May 9, March 28, January 27, 2014; December 10, October 28, August 26, July 18, May 31 and 9, April 11, February 26 and 1, January 9, 2013; December 5, November 15, October 24, 11 and 5, July 10, June 5, May 2, April 23 and 16, March 12 and 5, February 22, January 27 and 26, 2012, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins